Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

David Grant U.S. Air Force Medical Center

Status: Terminated

Conditions: Diabetes Mellitus

Study type: Observational

Funder types: Other U.S. Federal agency

Identifiers

NCT02040025

FDG20140010H

Details and patient eligibility

About

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

Enrollment: 2 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age equal to or greater than 18
2. Diagnosis of Type 1 or Type 2 diabetes mellitus
3. Prescribed EECP therapy in the DGMC EECP clinic
4. Medically cleared for EECP therapy
5. TRICARE beneficiary

Exclusion criteria

1. DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus